Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted March 4, 2016
Federal Court Shuts Down Seller of Supplement Promoted for Herpes
The company claimed its product, which contained a combination of lysine, zinc and other ingredients, could treat herpes outbreaks. Statements made on its website included "New Herpes Treatment! Cure for Herpes Outbreaks" and "Viruxo Anti-Viral Support ...Never Have A Herpes Outbreak Again!"
(See ConsumerLab.com's Review of Lysine Supplements for tests of related products).
The FDA issued Viruxo a warning letter in 2011, for making these claims. Although the company responded that it would address these and other violations noted in the warning letter, it continued to market the product as a treatment for herpes.
The injunction issued against Viruxo requires to the company to remove all drug claims from its website and to notify the FDA at least 14 days before the creation of a new website.
See Related Warnings:
To read the FDA's press release, use the link below.